Benjamin Lacas

3.1k total citations
28 papers, 534 citations indexed

About

Benjamin Lacas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Benjamin Lacas has authored 28 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Otorhinolaryngology. Recurrent topics in Benjamin Lacas's work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (11 papers) and Head and Neck Cancer Studies (8 papers). Benjamin Lacas is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (11 papers) and Head and Neck Cancer Studies (8 papers). Benjamin Lacas collaborates with scholars based in France, United States and Canada. Benjamin Lacas's co-authors include Jean‐Pierre Pignon, Pierre Blanchard, Jean Bourhis, Jan B. Vermorken, Abderrahmane Bourredjem, Juan Jesús Cruz, Adriano Paccagnella, Marshall R. Posner, G. Calais and Ricardo Hitt and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Benjamin Lacas

26 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Lacas France	9	292	258	234	190	114	28	534
Jeltje Schulten Germany	10	222 0.8×	313 1.2×	334 1.4×	173 0.9×	49 0.4×	14	603
L.L. Siu Canada	7	169 0.6×	228 0.9×	176 0.8×	171 0.9×	35 0.3×	21	438
Li-Ting Liu China	14	121 0.4×	288 1.1×	310 1.3×	160 0.8×	72 0.6×	27	475
Jin‐Jie Yan China	10	110 0.4×	292 1.1×	191 0.8×	173 0.9×	49 0.4×	15	375
Nathalie Syz France	5	292 1.0×	85 0.3×	283 1.2×	102 0.5×	57 0.5×	5	490
Whee-Sze Ong Singapore	5	98 0.3×	200 0.8×	274 1.2×	144 0.8×	33 0.3×	6	417
O S.K. China	6	221 0.8×	567 2.2×	303 1.3×	430 2.3×	51 0.4×	7	661
Neus Basté Spain	10	114 0.4×	142 0.6×	213 0.9×	81 0.4×	54 0.5×	32	335
Carlo Furlan Italy	13	252 0.9×	88 0.3×	180 0.8×	98 0.5×	113 1.0×	29	515
Swan‐Swan Leong Singapore	6	291 1.0×	91 0.4×	246 1.1×	62 0.3×	70 0.6×	7	461

Countries citing papers authored by Benjamin Lacas

Since Specialization

Citations

This map shows the geographic impact of Benjamin Lacas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lacas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lacas more than expected).

Fields of papers citing papers by Benjamin Lacas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lacas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lacas. The network helps show where Benjamin Lacas may publish in the future.

Co-authorship network of co-authors of Benjamin Lacas

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Lacas. A scholar is included among the top collaborators of Benjamin Lacas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Lacas. Benjamin Lacas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Limkin, Elaine Johanna, Pierre Blanchard, Benjamin Lacas, et al.. (2023). Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses. Radiotherapy and Oncology. 190. 110011–110011. 1 indexed citations

Lacas, Benjamin, Olivier Gléhen, Denis Smith, et al.. (2022). Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment. Cancer Treatment and Research Communications. 34. 100674–100674. 4 indexed citations

Ramaekers, Bram, Benjamin Lacas, C. Le Péchoux, et al.. (2022). Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer. Radiotherapy and Oncology. 170. 95–101. 1 indexed citations

Ramaekers, Bram, Benjamin Lacas, C. Le Péchoux, et al.. (2021). Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. Radiotherapy and Oncology. 158. 40–47. 6 indexed citations

Saghatchian, Mahasti, Benjamin Lacas, Cécile Charles, et al.. (2021). BEAUTY and the breast: is adjuvant chemotherapy the right time for a beauty boost? Lessons learned from a large randomized controlled trial. Quality of Life Research. 31(3). 723–732. 1 indexed citations

Pautier, Patricia, Anne Floquet, Christine Chevreau, et al.. (2020). A single-arm multicenter phase II trial of doxorubicin (Doxo) in combination with trabectedin (Trab) given as first-line treatment to patients with metastatic/advanced uterine (U-LMS) and soft tissue leiomyosarcoma (ST-LMS): Final results of the LMS-02 study.. Journal of Clinical Oncology. 38(15_suppl). 11506–11506.

Lacas, Benjamin, Olivier Bouché, Pierre-Luc Etienne, et al.. (2019). Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. Expert Review of Pharmacoeconomics & Outcomes Research. 19(5). 601–608. 2 indexed citations

Petit, Claire, et al.. (2018). Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience. BMJ Open. 8(8). e020499–e020499. 3 indexed citations

Seymour, Lesley, Gwénaël Le Teuff, Élisabeth Brambilla, et al.. (2018). LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non–small-cell Lung Cancer. Clinical Lung Cancer. 20(2). 66–73.e6. 19 indexed citations

10.

Lacroix, Ludovic, Benjamin Lacas, Julien Adam, et al.. (2017). Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients. Oncotarget. 8(15). 25189–25199. 11 indexed citations

11.

Lassen, P., Benjamin Lacas, Jean‐Pierre Pignon, et al.. (2017). Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. Radiotherapy and Oncology. 126(1). 107–115. 94 indexed citations

12.

Ma, Xiaoli, Gwénaël Le Teuff, Benjamin Lacas, et al.. (2016). Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Journal of Thoracic Oncology. 11(6). 850–861. 77 indexed citations

13.

Masip, J. Remon, et al.. (2016). ANSELMA: ANtiangiogneic SEcond line Lung cancer Meta-Analysis in non-small cell lung cancer (NSCLC). Annals of Oncology. 27. vi441–vi441. 1 indexed citations

14.

Lévy, Antonin, É. Bardet, Benjamin Lacas, et al.. (2016). A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer. Oncotarget. 8(9). 15924–15933. 13 indexed citations

15.

Ducreux, Michel, Olivier Gléhen, Denis Smith, et al.. (2016). Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC). Annals of Oncology. 27. vi161–vi161.

16.

Blanchard, Pierre, Jean Bourhis, Benjamin Lacas, et al.. (2015). Méta-analyses d’essais randomisés sur données individuelles dans le traitement des cancers ORL non métastatiques : principes, résultats, perspectives. Cancer/Radiothérapie. 19(3). 198–204. 2 indexed citations

17.

Seymour, Lesley, Gwénaël Le Teuff, Ming‐Sound Tsao, et al.. (2014). Prognostic and Predictive Biomarkers for Act (Adjuvant Chemotherapy) in Resected Non-Small Cell Lung Cancer (R-Nsclc): Lace-Bio. Annals of Oncology. 25. iv58–iv58. 2 indexed citations

18.

Graziano, Stephen L., Benjamin Lacas, Robin T. Vollmer, et al.. (2013). Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA. Lung Cancer. 82(1). 149–155. 8 indexed citations

19.

Blanchard, Pierre, Jean Bourhis, Benjamin Lacas, et al.. (2013). Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group. Journal of Clinical Oncology. 31(23). 2854–2860. 182 indexed citations

20.

Hainaut, Pierre, Xiuli Ma, Benjamin Lacas, et al.. (2012). Lace-Bio Pooled Analysis of the Prognostic and Predictive Value of TP53 Mutations in Completely Resected Non Small Cell Lung Cancer (NSCLC). Annals of Oncology. 23. ix389–ix389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact